通化東寶(600867.SH)業績快報:2020年度淨利升14.51%至9.29億元
格隆匯1月14日丨通化東寶(600867.SH)披露2020年度業績快報,報吿期內,公司實現營業收入29.25億元,同比增長5.32%;營業利潤11.76億元,同比增長21.52%;利潤總額11.23億元,同比增長17.86%;實現歸屬於上市公司股東淨利潤9.29億元,同比增長14.51%;基本每股收益0.46元。
報吿期內,歸屬於上市公司股東的淨利潤同比增長14.51%,其主要原因是:公司銷售收入的穩步增長促進了生產規模的擴大,公司整體規模效應增強,公司原輔料採購成本下降,毛利率水平有明顯提升,同時公司逐步加強對銷售費用等費用的管控。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.